Ubie Symptom AI
Free AI symptom checker built by doctors — get a personalised health report in 3 minutes, 24/7.
Overview
Ubie is an AI-powered symptom checker developed by Japanese health-tech company Ubie, Inc. Users answer roughly 20 doctor-designed questions about their symptoms and receive a personalised report covering possible diagnoses across 1,100+ conditions, recommended medical departments to visit, and treatment guidance — all in around three minutes. The AI is trained on 50,000+ peer-reviewed medical publications, continuously refined by 50+ specialist physicians, and has been validated across 1,500+ real-world healthcare provider organisations globally. A 2024 clinical vignette study (medRxiv) found Ubie's Top-10 diagnostic accuracy at 71.6%, comparing favourably to the median physician benchmark of 72.9% and outperforming rival symptom checkers.
Beyond the consumer product, Ubie operates a B2B arm ("Ubie Business") that provides AI-driven patient intake, triage, and chronic-disease management tools to over 1,800 healthcare organisations in Japan and is now expanding these provider solutions in the US — including a February 2026 collaboration with Mayo Clinic to co-develop "Ubie Smart Support," a unified AI-powered digital front door. A separate "Ubie for Pharma" division serves 21 of the top 30 global life sciences companies with patient-funnel analytics and disease-awareness data.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 16 Jun 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
Use cases
What you can produce with Ubie Symptom AI
- Personalised symptom report listing likely conditions ranked by probability within about 3 minutes
- Guidance on urgency level — whether to seek emergency care, schedule an appointment, or manage at home
- Recommended medical department or specialist type based on reported symptoms
- Doctor's Note feature summarising symptoms for easier communication with a physician
- Chronic-condition tracking dashboard via the Checkup platform for patients managing ongoing health issues
- Disease prevalence and patient-funnel analytics for pharmaceutical clients via Ubie for Pharma
- Enterprise AI triage and patient intake automation for health systems via Ubie Business
ASEAN Perspective
Ubie Symptom AI in Southeast Asia
Ubie, Inc. opened a Singapore office in 2020 — the earliest sign of ASEAN ambition — and its co-founders have cited the region as a long-term expansion target. However, as of mid-2026, the consumer symptom checker is effectively built around the US and Japan markets: care-routing, clinic recommendations, and regional disease weighting skew strongly towards those geographies, offering limited utility for users in Malaysia, Indonesia, the Philippines, or Vietnam who need local provider referrals. ASEAN users can still use the free symptom-information layer, but should treat care-pathway suggestions with caution given the lack of local health-system integration.
Ubie stands out as one of the few symptom checkers with a peer-reviewed accuracy study behind it — a Top-10 diagnostic hit rate of 71.6% in a 2024 medRxiv clinical vignette analysis, rivalling the physician benchmark of 72.9% and surpassing competing tools. The consumer product is genuinely free, requires no sign-up, completes in three minutes, and is continuously overseen by a panel of 50+ medical specialists. Backed by over $125M in cumulative funding (investors include Google, Rakuten, Mizuho, and Dai-Ichi Life) and now co-developing an enterprise-grade platform with Mayo Clinic, Ubie has credible institutional validation that most AI health apps lack.
The main caveats for RECATOOLS readers: the symptom checker is heavily US-centric in its care-routing recommendations (local clinic finder, US-specific insurance context) and provides no public developer API — integration is only available via closed B2B enterprise contracts. ASEAN coverage is limited despite a Singapore office established in 2020; the app does not surface local ASEAN clinics or localised disease prevalence data for markets like Malaysia, Indonesia, or the Philippines. It also cannot substitute for a licensed physician and explicitly advises users to seek professional care for anything beyond informational guidance.
What people say
Ubie is a medically grounded, genuinely free symptom checker with unusually strong institutional backing — over $125M in cumulative funding from investors including Google, Rakuten, and Mayo Clinic, published accuracy research, and a 2026 collaboration with Mayo Clinic on an AI triage platform. Its consumer product is fast, jargon-light, and needs no sign-up. Weaknesses include a heavy US-and-Japan focus for care routing, no public developer API, and limited ASEAN localisation despite a Singapore presence. For users seeking informational health guidance rather than a local clinic referral, it is one of the more credible free tools available.
Summary of public user & expert reviews, compiled by RECATOOLS.
Notable facts
- Co-founder Dr Yoshinori Abe left clinical medicine after a patient died from late-stage colon cancer that could have been caught earlier — motivating the creation of an AI early-detection tool.
- Ubie was ranked #1 on LinkedIn's 2021 Top Startups list in Japan.
- A 2024 peer-reviewed clinical study found Ubie's Top-10 diagnostic accuracy (71.6%) nearly matches the median physician benchmark (72.9%) on the same set of 328 clinical vignettes.
- Ubie for Pharma already counts 21 of the top 30 global life sciences companies among its clients, including partnerships with Pfizer, Boehringer Ingelheim, and Takeda.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Ubie Symptom AI's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Ubie Symptom AI unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Ubie Symptom AI directly →
Spotted something out of date? Suggest an update →
Ubie Symptom AI in the news
Health & Wellness
The Oura Ring 5 is here, smaller and screenless, as smart rings have a moment
Health & Wellness
HealthTechX Asia 2026 Convenes 60+ Speakers and 90+ Partners in Singapore — MOH National D...
Health & Wellness
AI Is Coming For Cancer and Obesity: Novo Nordisk's OpenAI Partnership Signals Medicine's...
Alternatives to Ubie Symptom AI
More in Other
